Orange Book product · Generic (ANDA)
ELETRIPTAN HYDROBROMIDE
ELETRIPTAN HYDROBROMIDE
At a glance
Jul 13, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 13, 2022
4 yr ago
Today
Pharmaceutical detail
Active ingredient
ELETRIPTAN HYDROBROMIDE
Strength
EQ 20MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 215467
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ELETRIPTAN HYDROBROMIDE
- 2002RELPAXBrand (NDA)
NDA 021016 · UPJOHN
- 2025ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 219143 · ANNORA PHARMA
- 2020ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 209680 · CARLSBAD
- 2019ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 210708 · AUROBINDO PHARMA
- 2018ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 206787 · STEVENS J
- 2017ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 205186 · CHARTWELL RX
- 2017ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 205152 · MYLAN
- 2017ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 202040 · TEVA PHARMS USA
- 2017ELETRIPTAN HYDROBROMIDEGeneric (ANDA)
ANDA 206409 · ZYDUS PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
